Increase in Types 1 and 2 Diabetes Seen in U.S. Youth During Pandemic
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Sept. 26, 2023 -- The incidence of type 1 and type 2 diabetes increased among U.S. youth during the COVID-19 pandemic, according to a study published online Sept. 21 in JAMA Network Open.
Matthew T. Mefford, Ph.D., from Kaiser Permanente Southern California in Pasadena, and colleagues examined diabetes incidence rates among youth (from birth to 19 years) in the United States using data from Kaiser Permanente Southern California between Jan. 1, 2016, and Dec. 31, 2021. The age- and sex-standardized annual and quarterly incidence rates were calculated per 100,000 person-years (PYs) for type 1 and type 2 diabetes.
The researchers found 1,200, 1,100, and 63 patients had type 1 diabetes, type 2 diabetes, and other diabetes, respectively, between 2016 and 2021. The incidence of type 1 diabetes increased from 18.5 to 22.4 per 100,000 PYs in 2016-2019 to 2020-2021, with increased incidence rate ratios (IRRs) for those aged 10 to 19 years, males, and Hispanics. Type 2 diabetes incidence increased from 14.8 to 24.7 per 100,000 PYs from 2016-2019 to 2020-2021, with increased IRRs among those aged 10 to 19 years, males and females, and those with Black, Hispanic, and other/unknown race and ethnicity.
"Future research to understand potential underlying physiologic and behavioral risk factors before and during the pandemic among individuals at high risk for incident diabetes is warranted," the authors write.
Mefford disclosed receiving grants from Merck, Sharp, & Dohme.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Further Support and Information on COVID-19
Read this next
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease
FRIDAY, June 7, 2024 -- For adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists...
Diabetes Tied to Higher Prevalence of Overactive Bladder
TUESDAY, June 4, 2024 -- Markers of diabetes are positively associated with overactive bladder (OAB), according to a study published online April 28 in Frontiers in...
No Decline in Cardiovascular Events Seen With COVID-19 Vaccine After Acute Coronary Syndromes
MONDAY, June 3, 2024 -- Patients who have received at least one COVID-19 vaccine dose after acute coronary syndromes do not have a reduced risk for cardiovascular events...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.